phosphorylation sites have been identified in both, including sites for the Src kinase 21 and, in particular, for PKC 21, 23 .
Here we show that Flot1 is required for the PKC-triggered endocytosis of the NTTs DAT and EAAT2. Further analysis revealed that DAT forms a complex with palmitoylated Flot1 in a PKC-dependent manner, and that a conserved serine residue of Flot1 is required for PKC-mediated internalization of DAT. Moreover, Flot1 is required to maintain DAT in membrane rafts, suggesting that membrane microdomain localization may be an important determinant of regulated endocytosis of DAT. Notably, despite previous results indicating that DAT localization influences its ability to transport DA, we found no detectable effect on DA uptake after Flot1 depletion. In contrast, depletion of Flot1 diminished amphetamine-induced reverse transport of DA in neurons. These findings indicate that membrane microdomain localization can influence both PKC-triggered internalization and amphetamine's actions on DAT.
RESULTS PKC-triggered internalization of DAT Studies using heterologous systems have shown that DAT and EAAT2 rapidly internalize into endocytic structures in response to activation of PKC by the phorbol ester PMA [1] [2] [3] [4] [5] [6] . As shown by both confocal microscopy and cell surface biotinylation, HEK293-derived EM4 cells stably expressing enhanced yellow fluorescent protein (eYFP)-tagged DAT (EM4-YFP-DAT) 2 or HeLa cell lines stably expressing monomeric YFP 24 (mYFP)-tagged DAT (HeLa-mYFP-DAT) or eGFP-tagged EAAT2 (HeLa-eGFP-ET2) show robust and rapid internalization of the transporter into early endosomal antigen-1 (EEA1)-positive vesicles in response to a 30-min exposure to PMA (Fig. 1a,b and Supplementary Fig. 1 ). It has previously been shown that the murine homolog of EAAT2, GLT-1, internalizes in response to PMA in neuron-astrocyte cocultures 4, 6 . To ascertain whether this PKC-triggered event also is observed with endogenous DAT, we exposed primary dopaminergic neurons to 1 µM PMA (direct PKC activation) for 30 min and immunostained for DAT. Confocal imaging revealed that PKC activation led to significant redistribution of endogenous DAT to an internal compartment in primary neurons (Fig. 1c) . Consistent with these findings, PMA treatment of mouse striatal slices led to a significant internalization of endogenous DAT, as shown by cell surface biotinylation (Fig. 1d) . Thus, PKC-triggered internalization of DAT is evident not only in a heterologous system but also in primary neurons and brain slice preparations expressing endogenous DAT.
How is PKC-triggered internalization achieved? Mutagenesis of canonical PKC phosphorylation sites in DAT did not affect its PKCregulated endocytosis in heterologous systems 25, 26 , suggesting that rather than directly phosphorylating the transporter, PKC controls internalization by phosphorylating an unknown intermediary protein.
Because structurally distinct NTTs can be internalized in response to PMA, and this PMA-triggered event is observed across a wide range of cells ( Fig. 1 and Supplementary Fig. 1 ), the intermediary protein may be a ubiquitous protein involved in fundamental cellular trafficking events. Preincubating EM4-YFP-DAT with the reversible PKC inhibitor Gö6850 (also known as bisindolylmaleimide I or GF109203X) inhibited PMA-triggered internalization in a dose-dependent manner (Fig. 2a,b) . We hypothesized that overexpression of the requisite target of PKC for internalization would compete with the inhibitor for binding, as Gö6850 reversibly binds the substrate binding site of PKC, and consequently enhance internalization at low effective concentrations of the inhibitor (Supplementary Fig. 2 ).
Flot1 is required for DAT and EAAT2 internalization by PKC
To determine the effect of membrane raft localization on PKCtriggered internalization of DAT, we first tested Cav1 ( Supplementary  Fig. 3 ). Despite robust internalization in EM4-YFP-DAT cells (Fig. 1) , as previously reported for some HEK293 cells 27, 28 , we could not detect Cav1 protein in the HEK-293-derived EM4 cells ( Supplementary  Fig. 3a ) 29 . Furthermore, in the presence of Gö6850, Cav1 overexpression failed to blunt inhibition ( Supplementary Fig. 3b,c) . In HeLa cells, which do express endogenous Cav1, small interfering RNA (siRNA)-mediated knockdown of Cav1 also had no effect on PMAtriggered DAT internalization (Supplementary Fig. 3d ), further indicating that Cav1 is not required for this event.
We next turned to Flot1. Confocal imaging and cell surface biotinylation showed that overexpression of Flot1 in EM4-YFP-DAT diminished the Gö6850-mediated inhibition of PMA-triggered DAT internalization (Fig. 2a,c) . PMA-triggered endocytosis was assessed by confocal analysis as the number of cells that showed internalized DAT (into EAA1-positive compartments, indicating entry into early endosomes) after exposure to PMA. Although 0.1 µM Gö6850 led to approximately 60% inhibition of PMA-triggered endocytosis, overexpression of Flot1 significantly reduced this inhibition to 20%. -YFP-DAT internalizes (white arrows) into EEA1-positive vesicles after exposure to 0.5 µM PMA for 30 min. Cells exposed to PMA were fixed and immunostained for EEA1 as described. Alexa Fluor 633-labeled secondary antibodies were used to prevent overlap with YFP. Scale bars, 10 µm.
(c) Endogenous DAT internalizes in response to PMA in primary dopaminergic neurons. Midbrain cultures were treated with vehicle (Ctrl, n = 32) or 1 µM PMA (+ PMA, n = 35) for 30 min, fixed and immunostained for DAT (intracellular epitope). PMA led to significant internalization of DAT ('Internalization Index,' as described in Online Methods: Ctrl, 0.076 ± 0.013; PMA, 0.309 ± 0.052). One-way analysis of variance (ANOVA); P < 0.001. Scale bars, 20 µm. (d) Internalization of endogenous DAT in striatal slice preparations (n = 6). Slices were treated with 10 µM PMA or Ctrl for 1 h, then cell surface biotinylated to determine DAT surface levels. Graph indicates the relative amount of DAT at the cell surface, and calculated as the ratio between the integrated densities of surface DAT after treatment (corrected for total DAT) to surface DAT before treatment (corrected for total DAT). Bars represent mean + s.d. PMA treatment significantly decreased surface DAT (P = 0.0330). Complete blots can be found in Supplementary Figure 9 .
a r t I C l e S
To ensure that overexpression of Flot1 did not lead to a mis-sorting event, we performed immunocytochemistry after PMA administration to examine the vesicle population into which DAT entered. Staining with EEA1 revealed that Flot1 overexpression led to proper entry of DAT into an early endosomal compartment (Fig. 2b ) similar to that seen in wild-type conditions (Fig. 1b) . We next tested whether Flot1 was required for PMA-triggered internalization (Fig. 3) , using siRNA-mediated knockdown of Flot1.
Depletion of endogenous Flot1 abolished PMA-triggered internalization of DAT as shown by confocal microscopy and cell surface biotinylation (Fig. 3a,b) . These findings implicate Flot1 as a mediator of PKC-triggered internalization of DAT. Moreover, as depletion of Flot1 did not inhibit cell surface expression of DAT, this suggested that Flot1 is not required for the trafficking of DAT to the plasma membrane. Depletion of Flot1 using siRNA had no effect on the canonical, clathrin-mediated endocytosis of the transferrin receptor Supplementary Fig. 4a ), indicating that Flot1 is not required for all forms of endocytosis. Also consistent with previous reports, TfR internalization was unaffected by either PKC activation or PKC inhibition ( Supplementary Fig. 4b ) 30 . As EAAT2 also undergoes PMA-triggered internalization and also localizes to membrane rafts, we examined whether its internalization was also dependent on Flot1. HeLa-eGFP-EAAT2 cells showed robust internalization of eGFP-EAAT2 into EAA1-positive vesicles after a 30-min exposure to 0.5 µM PMA (Fig. 3c) . Using cell surface biotinylation, PMA-triggered internalization was reexamined after transfection with control siRNA (siCtrl) or siFlot1 (Fig. 3d) . Similarly to DAT internalization, depletion of Flot1 inhibited PMA-triggered internalization of EAAT2, suggesting that these NTTs share common endocytic machinery despite being structurally distinct.
Flot1 has previously been shown to delineate a discrete set of endocytic vesicles 17 . We therefore next determined whether DAT and EAAT2 were trafficked into Flot1-positive vesicles. Confocal microscopy showed that PKC-triggered internalization caused DAT to traffic into vesicles positive for Flot1 (Fig. 3e) but negative for Cav1 (Supplementary Fig. 3c ). Further inspection at higher magnification revealed a high degree of colocalization between Flot1 and DAT (Fig. 3e) . Similar results were obtained for EAAT2 (Supplementary Fig. 5 ).
Flot1 must be palmitoylated
Although recently implicated in endocytosis 17 , Flot1 often has been used as a marker of membrane rafts. Flot1 interacts with cholesterolrich membranes through palmitoylation 31 , a labile and reversible post-translational modification. Flot1 is palmitoylated on a conserved cysteine residue, Cys34, in its highly conserved prohibitin homology domain (PHB domain) 31 (Fig. 4a) . To examine the relevance of Flot1 palmitoylation for PKC-triggered endocytosis of DAT, we mutated Cys34 to alanine (Flot1(C34A)). As previously shown 31 , the palmitoylation-deficient mutant was distributed diffusely in the cytoplasm (Fig. 4b) . Similarly to Flot1 depletion, Flot1(C34A) overexpression did not alter basal trafficking of DAT to the plasma membrane in EM4-YFP-DAT (Fig. 4b) .
In contrast, Flot1(C34A) acted in a dominant negative manner to inhibit PMA-triggered endocytosis of DAT ( Fig. 4b-d) . Furthermore, Gö6850-mediated inhibition was not ameliorated by overexpression of Flot1(C34A) (Fig. 4c,d ). Flot1 previously has been reported to act as a multimer 20, 22 . In cells expressing Flot1(C34A), we observed residual staining that indicated plasma membrane localization of the palmitoylation-deficient mutant (Supplementary Fig. 6 ). We speculated that this may occur owing to the multimerization of the mutant with endogenous Flot1. We therefore used coimmunoprecipitation to examine Flot1 multimerization. Both Flot1-monomeric (Fig. 4e,f) , suggesting that the residual membrane localization was due to Flot1(C34A)'s interaction with endogenous Flot1. Palmitoylation deficiency, therefore, did little to alter the homomultimerization of Flot1; however, because PKCtriggered endocytosis was inhibited the resulting multimer was functionally altered. Loss of the key palmitoylation site likely destabilized the association of Flot1(C34A) to the plasma membrane, as demonstrated by its predominant expression in the cytosol. Endocytic machinery often can be found in a complex with its cargo. We therefore determined whether Flot1 and DAT were members of a complex, and whether the interaction was modulated by Flot1 palmitoylation or PKC activation. EM4-YFP-DAT cells were transiently transfected with Flot1-mRFP or Flot1(C34A)-mRFP and were exposed to vehicle or 1 µM PMA for 30 min. Flot1 was found in a complex with DAT, and this interaction was significantly reduced by the C34A mutation (Fig. 4f) . The presence of PMA did not significantly alter the interaction between DAT and Flot1 or between DAT and Flot1(C34A) (P = 0.1952, ANOVA). These data indicate that palmitoylation of Flot1 was required to permit Flot1 to complex properly with DAT. Our efforts to express and purify recombinant Flot1 were unsuccessful, and thus we were unable to determine whether this interaction was direct.
Flot1 is required to maintain DAT in membrane microdomains As DAT and Flot1 can be found in a complex, we next examined the segregation of DAT and Flot1 after detergent extraction and densitygradient centrifugation. Sucrose flotation experiments upon fractionation with Brij58, a nonionic polyoxyethylene surfactant detergent, showed that DAT segregated with Flot1 in low buoyancy fractions (Fig. 5a-e) 11 , indicating that they were found in similar detergentresistant membranes, as described previously 1, [9] [10] [11] . Notably, although knockdown of endogenous Flot1 had no detectable effect on DAT trafficking to the plasma membrane (Fig. 3a) , sucrose gradients revealed that Flot1 depletion altered the localization of DAT within the membrane: its distribution shifted to denser fractions in a manner similar to the distribution seen after cholesterol depletion by nystatin (Fig. 5) . In contrast, overexpression of Flot1(C34A) had no detectable effect on the distribution of DAT (Fig. 5b versus Fig. 5c,d ). This supports the finding that Flot1 can establish discrete domains within the membrane independent of caveolin 20, 22 , suggesting a heterogeneity of membrane domains. Thus, not only is Flot1 complexed to DAT, but its presence is also required to define the specific membrane domain within which DAT resides.
Previous studies have shown that the disruption of membrane rafts using methyl-β-cyclodextrin (MbC) inhibits the ability of DAT to uptake DA 1,9-11 . We therefore tested whether Flot1 depletion has a similar effect on DA uptake. Although we also found that MbC negatively affected DAT-mediated DA uptake in EM4-YFP-DAT cells (Supplementary Table 1 Fig. 5f and Table 1 ). K m and V max were also unaffected ( Table 1) . We hypothesize that the difference between MbC and Flot1 depletion may lie in MbC's mechanism of action: MbC extracts cholesterol from cell membranes by binding the cholesterol within its nonpolar cyclodextrin rings and forming soluble complexes. Removal of cholesterol may affect transport through direct effects on DAT and its ability to undergo the conformational changes associated with transport, as cholesterol engages in important functional interactions with many membrane proteins, including DAT 32 . To test this, we used another pharmacological agent, nystatin ( Fig. 5d and Table 1 ). Nystatin and filipin disrupt transfected as indicated and exposed to vehicle, then DA uptake assays were performed as described in Online Methods. Data is represented as [ 3 H]DA uptake as a percentage of that in wild type (WT). Neither the palmitoylation-deficiency mutation nor depletion of Flot1 significantly altered DA uptake (n = 4, P = 0.5770). Bars represent mean + s.e.m. Please also refer to Table 1 . Complete blots can be found in Supplementary Figure 13 .
4 7 4 VOLUME 14 | NUMBER 4 | APRIL 2011 nature neurOSCIenCe a r t I C l e S rafts differently from MbC: they directly insert into the membrane to bind free cholesterol, thus maintaining cholesterol within the membrane. We found that, similarly to Flot1 depletion, nystatin affected neither the K m nor V max of [ 3 H]tyramine uptake ( Table 1) , consistent with the lack of effect of filipin on DA uptake reported previously 10 . Taken together, these data indicate that membrane raft localization of DAT is not required for DAT-mediated DA uptake. Nonetheless, the functional effect of MbC but not nystatin, filipin or Flot1-depletion indicates that membrane cholesterol is somehow critical for DA uptake, presumably through direct interactions with DAT.
Flot1 is phosphorylated within a conserved PKC site
In the presence of PMA, Flot1 more efficiently forms a complex with DAT (Fig. 4f) . This enhanced interaction is reminiscent of Cav1-mediated endocytosis 15, 16 , whereby phosphorylation of Cav1 increases its affinity for cargo. Another feature of this model is that phosphorylation of Cav1 increases its multimerization. Consistent with this hypothesis, PKC activation increased the amount of endogenous Flot1 that immunoprecipitated with Flot1-mRFP (Fig. 6a) .
The ability of Flot1 to overcome Gö6850-mediated inhibition of PKC-triggered endocytosis and to multimerize in response to PMA suggested that Flot1 is a substrate of PKC. Upon activation by PMA or other stimuli, PKC rapidly translocates from the cytosol to the plasma membrane, where it can localize within Flot1-positive membrane rafts 33 . We therefore examined whether PKC activation led to phosphorylation of Flot1. In the initial characterization of Flot1, consensus sequences for four PKC, two tyrosine kinase and three casein kinase phosphorylation sites were identified 21, 34 . Although Flot1 has been shown to interact with the tyrosine kinase Src1 (ref. 35) and to internalize in response to Fyn activation 20, 36 , a panel of tyrosine kinase inhibitors (PP2, PP3, genistein or herbimycin A) had no effect on PKC-triggered redistribution of DAT (data not shown), suggesting that PKC might phosphorylate Flot1 directly or indirectly through another kinase. We therefore performed metabolic labeling experiments to examine the phosphorylation state of Flot1 in response to PMA (Fig. 6b and Supplementary Fig. 7 ). Cells transfected with Flot1-GFP were labeled with [ 32 P]orthophosphate in the presence of vehicle, PMA or PMA plus Gö6850 for 30 min as described in Online Methods. PMA led to a significant increase in Flot1 labeling that was inhibited by Gö6850, indicating that Flot1 was phosphorylated upon PKC activation.
To determine the site modified by PKC, we introduced point mutations of serine or threonine to alanine in the PKC consensus sequences of Flot1 (Fig. 4a) and transfected the resulting constructs into the EM4-YFP-DAT cells. All mutants localized to the plasma membrane like wild-type Flot1. Metabolic labeling experiments revealed that the Flot1(S315A) mutant incorporated significantly less 32 P than wild-type Flot1 (Fig. 6b) . To determine whether this was functionally significant, . Bars represent the integrated density of 32 P incorporation normalized (rel.) to Flot1, + s.e.m. ANOVA showed that PMA led to a significant increase in 32 P incorporation (P = 0.0474) that was inhibited by Gö6850 (P = 0.0017). S315A mutation inhibited this PMA-triggered increase (P = 0.1610). Overall 32 P incorporation was also significantly less in S315A mutant (P < 0.001). a r t I C l e S we examined PMA-triggered internalization of DAT. Although S54A-, T150A-and T229A-expressing cells showed robust internalization in response to PMA, cells expressing the S315A mutant had a significantly impaired response to PMA (Fig. 6c,d ; T150A and T229A are not shown). Surface biotinylation experiments confirmed the requirement of Ser315 for PKC-triggered internalization of DAT (Fig. 6d) . This result strongly suggested that activated PKC triggers endocytosis of DAT by phosphorylating Ser315 in Flot1. This SXR/K motif is largely conserved across species (Fig. 6e) and is adjacent to the oligomerization domain, where it might possibly influence multimerization.
Flot1 is required for AMPH-induced efflux of DA As catecholaminergic cells express both Flot1 mRNA and protein 37 , we extended our studies to primary dopaminergic neuronal cultures to examine the role of endogenous Flot1 on endogenous DAT. We showed previously that DAT-mediated transient currents are proportional to the number of transporters on the cell surface 2 . Thus, to determine whether Flot1 is also required for internalization of endogenous DAT, we used an electrophysiological approach to measure DAT in the plasma membrane at the single cell level. Midbrain DA neurons were cultured from mice expressing RFP driven by the tyrosine hydroxylase promoter as described previously 38 . Neurons were transduced at 5 d in vitro with lentivirus carrying turboGFP coexpressed with either shRNA against Flot1 (shFlot1) or a non-silencing shRNA control and recorded 5 d later ( Fig. 7a and Supplementary  Fig. 8 ). Only cells expressing both red and green fluorescence were examined. Under control conditions, DAT-mediated transient currents, which reflect DAT plasma membrane expression, decreased significantly in the presence of PMA, indicative of a PKC-triggered reduction of endogenous DAT cell surface expression in neurons (Figs. 1 and 7a) . Knockdown of Flot1 (shFlot1) blocked the ability of PMA to reduce DAT cell surface expression as measured by transient currents (Fig. 7a, bottom panel) . This confirmed that Flot1 was required for PKC-triggered endocytosis of endogenous DAT and, of key importance, indicated that the loss of Flot1 has functional consequences in neurons.
Amphetamine (AMPH), a substrate of DAT, exerts its psychostimulants effects by elevation of extracellular DA through DAT-mediated DA efflux 39 . This process has been shown to be regulated by PKC and calcium/calmodulin kinase IIα (CamKIIα) 38, 40 . To determine whether AMPH-mediated reverse transport of DA in primary DA neurons is also regulated by DAT localization and therefore dependent on Flot1, we recorded DAT-mediated DA efflux using amperometry combined with patch clamp in the whole-cell configuration. This technique permits the recording of DAT-mediated DA efflux under constant-voltage conditions 38 . Administration of 10 µM AMPH to the bath increased AMPH-induced DA efflux in a voltage-dependent manner (Fig. 7b) . Knockdown of Flot1 led to a significant inhibition of AMPH-induced DA efflux compared to non-silencing control, suggesting that Flot1-mediated localization of DAT in membrane rafts is required for efficient AMPH-induced reverse transport of DA.
DISCUSSION
We have identified Flot1 as a requisite intermediary of PKC-triggered endocytosis of two structurally distinct NTTs found in membrane rafts, DAT and EAAT2. Further examination showed that Flot1 is also a critical scaffold that maintains DAT in a cholesterol-rich environment within the plasma membrane. The membrane environment does not affect DAT-mediated uptake of DA, but instead is required for AMPH-induced reverse transport of DA. In summary, this study identifies DAT and EAAT2 as cargo for Flot1-mediated endocytosis, and it also demonstrates that Flot1 is likely to be important in synaptic function and homeostasis.
Metabolic labeling experiments demonstrated that PKC activation increased the phosphorylation of Flot1 on residue Ser315 (Fig. 6) . In turn, Flot1 increased its ability to homomultimerize (Figs. 4f and 6a ) and to interact with DAT (Fig. 4f) , supporting the model that Flot1-mediated endocytosis may be regulated similarly to caveolinmediated endocytosis 16, 22 . Sucrose gradient analysis also indicates that, like caveolin, Flot1 may form distinct, stable scaffolds to form subdomains within the plasma membrane, creating a microenvironment in which key components can organize. How multimerization of Flot1 influences its cargo selection, and what other cargo may be specific for Flot1, remain to be studied. Moreover, although Flot1 previously has been shown to interact with Src kinases 35 and the adaptor protein CAP 41 , as well as other proteins 23 , it is not yet certain what other adaptor proteins also may be required for internalization of DAT and EAAT2. Further examination of these questions will not only permit insights into DAT regulation and function, but will also permit greater insight into the endocytic machinery involved. Mean ± s.e.m. shFlot1 significantly reduced DA efflux as compared to shCtrl at voltages greater than 40 mV (*P < 0.05, **P < 0.01, one-way ANOVA followed by Bonferroni post hoc tests). VOLUME 14 | NUMBER 4 | APRIL 2011 nature neurOSCIenCe a r t I C l e S A role for DAT ubiquitination in its PKC-mediated-, clathrinand epsin-dependent internalization and subsequent degradation has previously been reported 42, 43 . Moreover, endocytosis studies in PAE cells 43 and LLC-PK1 cells 10 after nystatin and MbC treatment, respectively, showed that depletion of cholesterol from membranes does not disrupt PKC-triggered DAT internalization, suggesting that only the transporter present outside of membrane rafts is trafficked. Although different cell lines have been used in these studies, and differences in constitutive endocytosis levels should be considered, it is not yet clear whether our findings with Flot1 represent an independent trafficking pathway or a Flot1-dependent form of clathrin-mediated DAT endocytosis. Although it is conceivable that Flot1 organizes DAT for clathrin-mediated endocytosis as a previously undescribed adaptor protein, a previous study 17 reported that Flot1-mediated internalization of cargo is both clathrin and Cav1 independent. Moreover, the highly homologous Flot2 also internalizes in a clathrin-independent manner 20 .
A likely scenario is that DAT (and possibly EAAT2 as well) may be internalized by different pathways, leading to different final destinations. In the case of the TGF-β receptor 44 , caveolin-dependent internalization leads to rapid receptor degradation, whereas clathrindependent internalization promotes TGF-β recycling and signaling. Similarly, DAT may be sorted by Flot1 into a recycling pool and by clathrin into a degradation pool or vice versa. Clathrin-and epsinmediated internalization and the endocytosis of proteins associated in membrane rafts have been considered to be essentially mutually exclusive 45 , and it is possible that one means by which this sorting is achieved is by the membrane localization of DAT within Flot1-positive and possibly other microdomains. Sorting also may depend upon the strength and duration of the trigger. For example, sustained exposure to low concentrations of PMA has been shown to lead to internalization of a GPI-linked cargo, CD59 (ref. 46) . Although the depletion of Flot1 inhibits DAT internalization after 1 µM PMA for 30 min, preliminary evidence indicates that DAT-positive intracellular vesicles can be observed after 0.1 µM PMA exposure for 2 h (data not shown). More studies examining the kinetics of internalization, recycling and degradation of DAT and mechanisms of Flot1-mediated endocytosis will help define the relationship between the roles of clathrin and Flot1. Moreover, since endogenous DAT in both primary cultures (Fig. 1c) and slices (Fig. 1d) also can internalize in a PKC-dependent manner, studies in endogenous systems will also shed light on the cell surface regulation of endogenous DAT.
An unexpected finding of our studies is that Flot1 is required to maintain DAT in membrane rafts. In light of these findings, a step-wise transition from a membrane microdomain to a clathrindependent endocytic event outside of membrane rafts may be possible. A similar model has been reported for the tetanus neurotoxin fragment (TeNT HC) receptor, which is maintained in lipid microdomains by binding to the protein GD1b. Dissociation from GD1b permits TeNT HC receptor to exit from the membrane raft and internalize in a clathrin-dependent (albeit epsin-independent) fashion. Flot1 may similarly 'hold' DAT in membrane rafts, although in immunoprecipitation studies PKC activation increased rather than decreased the interaction between Flot1 and DAT (Fig. 4f) , and thus different regulatory mechanisms may be at play.
Disruption of membrane rafts through cholesterol depletion using MbC has been shown to affect DAT 10 and the structurally similar SERT 9,11 transport activity in heterologous systems. Consistent with previous reports, we have found that MbC impairs DAT transport activity (Supplementary Table 1) ; however we also find that Flot1 depletion and nystatin treatment do not ( Table 1) .
This indicates that the effect of MbC on transport activity does not result only from disruption of rafts, and the presence of membrane cholesterol is important for DAT function. Although DAT transport activity is unaffected, the Flot1-dependent membrane microdomain environment in neurons is very important for AMPH-induced DA efflux in DA neurons. The loss of DA efflux after Flot1 depletion suggests that the behavioral effects of AMPH would be inhibited in the absence of Flot1. We are testing this hypothesis in different animal models to establish whether there is a link between localization of DAT in Flot1-positive cholesterol-rich membrane microdomains and the behavioral consequences due to AMPH-mediated DA efflux.
METHODS
Methods and any associated references are available in the online version of the paper at http://www.nature.com/natureneuroscience/.
Note: Supplementary information is available on the Nature Neuroscience website. Flotillin-1 constructs. hFlot1 was purchased from Origene. hFlot1 was subcloned into pClontech monomeric dsRED (mRFP; Clontech) or pcDNA3.1(+) (Invitrogen). Site-directed mutagenesis was performed using QuikChange (Stratagene).
ONLINE METHODS

Reagents
Transfections and transductions. siRNAs were used singly at a final concentration of 10 nM, or as a mix of two siRNAs as described 17 , and transfected into cells using Oligofectamine. Lentiviruses carrying shFlot1 or non-silencing shRNA with turboGFP were created per manufacturer's instructions. Primary neurons were transduced on the fifth day in vitro with multiplicity of infection of 8.
cell culture. Production of stable cell lines: cDNAs clones expressing DAT, SERT and EAAT2 were subcloned by PCR into pEGFP-C1 and pEYFP-C1 then pIREShyg3. Cells were transfected, then individual clones were selected using 400 or 200 µg ml −1 hygromycin for HeLa and HEK293 cells, respectively.
EM4-YFP-DAT were created as described previously 2, 47 . EM4 cells are human embryonic kidney 293 cells modified to increase their adherence to tissue culture plastic 29 .
Primary mesencephalic dopaminergic neurons were generated as described 38 .
Transporter internalization assay. Cell lines. To initiate endocytosis, cells were rinsed twice with PBS and once with Krebs-Ringer's-HEPES (KRH) then incubated with KRH + PMA for 30 min at 37 °C. Internalization was stopped with cold KRH. Gö6850 was administered in 30 min before PMA administration, and maintained for the duration of the experiment. Primary cultures. Neurons were incubated in KRH + glucose for 1 h at 37 °C. Cultures were treated for 30 min with PMA and then fixed.
Brain slices. Mice were handled using Vanderbilt University Institutional Animal Care and Use Committee approved procedures. Mice 6 to 10 weeks old were anesthetized with isoflurane and rapidly decapitated. Brains were chilled in 4 °C oxygenated sucrose solution (sucrose 210 mM, NaCl 20 mM, KCl 2.5 mM, MgCl 2 1 mM, NaH 2 PO 4 1.2 mM), then sliced into 300-µm coronal slices. Slices were collected then washed twice with oxygenated artificial cerebral spinal fluid (ACSF) (NaCl 125 mM, KCl 2.5 mM, NaH 2 PO 4 1.2 mM, MgCl 2 1 mM, CaCl 2 2 mM). Slices were treated for 1 h with PMA then cell surface biotinylated.
cell surface biotinylation assays. Stable cell lines. Cell surface proteins were biotinylated with the membrane-impermeant reagent sulfo-NHS-LC-biotin in PBS containing 1 mM MgCl 2 , 0.1 mM CaCl 2 (PBS 2+ ). Cells were subsequently washed in PBS 2+ , lysed in a 1% Triton X-100 buffer containing protease inhibitors, and cleared by centrifugation. Biotinylated proteins were separated from unbiotinylated by , incubation overnight at 4 °C with equilibrated NeutrAvidin agarose beads (Pierce).
Brain slices. Slices were incubated with 4 °C ACSF solution containing 1 mg ml −1 EZ-Link sulfo-NHS-SS-biotin for 45 min. After biotin incubation, the slices were rinsed quickly twice and the reaction was quenched by two 20-min washes in 4 °C oxygenated ACSF plus glycine. After quenching, slices were lysed in buffer B (25 mM HEPES, 150 mM NaCl, 2 mM Na 3 VO 4 , 2 mM NaF plus a cocktail of protease inhibitors) plus 1% Triton X-100, then centrifuged at 17,000g for 30 min at 4 °C. Biotinylated proteins were isolated using ImmunoPure immobilized streptavidin beads overnight at 4 °C with agitation. Beads were washed three times with buffer B + 0.1% Triton X-100, and biotinylated proteins were eluted in 50 µl of 2× SDS-PAGE sample loading buffer at 95 °C and probed for DAT 48 .
Immunofluorescence. Stable cell lines. Cells were fixed either with 4% paraformaldehyde for 5 min at room temperature (25 °C), or with methanol for 20 min at −20 °C (anti-Cav1, anti-Flot1 immunofluorescence). Cells were washed three times with PBS (or PBS plus 0.01% Triton X-100 to permeabilize) and blocked with 5% normal goat serum in PBS. Primary antibodies were diluted in blocking solution (EEA1, 1:1,000; Cav1, 1 µg ml −1 ; Flot1, 1:100), and incubated overnight at 4 °C. Cells were washed three times with PBS and incubated with secondary antibody for 1 h at room temperature (25 °C) .
Primary neurons. Permeabilized cultures were blocked with PBS, 5% BSA, 0.05% Tween-20 (PBSBT) and treated with anti-DAT antibody (intracellular epitope; Chemicon) in PBSBT for 4 h at room temperature (25 °C) or overnight at 4 °C. Cultures were washed with PBSBT, incubated in secondary antibodies conjugated to Alexa 568, and imaged. microscopy and image analysis. Stable cell lines. Cells were grown on glass (HeLa) or poly-d-lysine coated (HEK-293, EM4) coverslips. After treatments, cells were fixed for 10 min in 4% paraformaldehyde. Percentage of cells with internalization was calculated as cells considered positive for internalization (YFP-DAT colocalized to EEA1-positive endosomes) after 30 min in PMA. Images were acquired using a Leica TCS SP2 confocal microscope at ×40 or ×63 magnification and the accompanying software package. Data analysis was performed using National Institutes of Health Image 4.0 (http://rsb.info.nih.gov/nih-image/).
Primary neurons. Cells were imaged on an Olympus FLUOVIEW FV1000 with a 60×, numerical aperture 1.42 lens. Data were collected using 16-bit data. The maximal brightness was established at the surface and internal compartment by thresholding. Background values were determined and subtracted. The internalization index was calculated by dividing the maximal brightness of the interior by the maximal brightness of the surface.
Transferrin uptake assay. Stable cell lines were incubated in KRH medium with 0.2% BSA for 1 h at 37 °C with 5.0% CO 2 to remove surface-bound transferrin. The cells were washed twice in ice-cold KRH then incubated in 5 µg ml −1 of Alexa 633-conjugated transferrin at 4 °C. Internalization was initiated by warming the cells to 37 °C for the times indicated and was stopped by washing repeatedly with ice-cold PBS.
Sucrose flotation gradients. EM4-YFP-DAT cells were transiently transfected with Flot1 or Flot1(C34A) 24 h before lysis or with siCTRL or siFlot1 48 h before lysis. For detergent treatment experiments, cells were exposed to 25 µg ml −1 nystatin. For lysis, cells were washed twice with ice-cold PBS and lysed in 1 ml HEPES-buffered saline containing 1% (wt/vol) Brij 58 (a nonionic polyoxyethylene surfactant detergent; Sigma) and protease inhibitors for 30 min at 4 °C. Lysates were homogenized with 15 passages through a 20-gauge needle, transferred to a microcentrifuge tube and centrifuged at 4 °C for 10 min at 830g. Cell supernatant (1 ml) was mixed with an equal volume of 80% (wt/vol) sucrose in HEPES buffer, transferred to an ultracentrifuge tube, and then carefully overlaid with 1 ml of 30% (wt/vol) sucrose in HEPES buffer, 1 ml of 15% (wt/vol) sucrose in HEPES buffer and finally 0.75 ml of 5% (wt/vol) sucrose in HEPES buffer. The tube was placed in a cooled SW55Ti swinging-bucket rotor, and centrifugation was carried out in a Beckman ultracentrifuge at 4 °C for 20 h at 45,000 r.p.m. Ten equivolume fractions were collected from top to bottom of the gradient. dA and tyramine uptake assay. Cells were placed on ice and washed three times with ice-cold KRH buffer after PMA internalization. Cells were then administered [ 3 H]DA and 3 µM cold DA in KRH buffer and returned to the incubator for 1 min at 37 °C. To terminate uptake, cells were quickly transferred to ice and the DA-containing buffer was aspirated. Cells were washed three times with icecold KRH buffer. Cells were permeabilized using 0.1% Triton X-100 in PBS, then measured for radioactivity. To determine nonspecific uptake, a subset of cells was also exposed to 25 nM GBR12935. To obtain K m and V max values, [ 3 H]tyramine uptake competition assays were also performed as previously described 49 .
Immunoprecipitation and immunoblotting. Cells were lysed with 50 mM Tris HCl, pH 7.4, 150 mM NaCl, 5 mM EDTA, protease inhibitor cocktail (Roche) and 1% Triton X-100 on ice for 30 min. All solutions were prechilled and all steps in the lysis procedure were performed on ice. After preclearing with 100 µl of protein A-agarose slurry with 1 ml of protein, 1 µg ml −1 of lysate were incubated overnight either with anti-mRFP or anti-Flot1 followed by protein A-agarose bead slurry (50 µl of a 50% suspension, Invitrogen) 1 h at 4 °C with gentle agitation;
